Amniotic stem cell transplantation therapy for type 1 diabetes: A case report

Journal of International Medical Research

Volumn 41, Issue 4, 2013, Pages 1370-1377

  Liu, Ying ^a,b   Cao, Dong Lin ^c   Guo, Li Bin ^a   Guo, Sheng Nan ^a   Xu, Jin Kai ^a   Zhuang, Hong Feng ^a  

^a Siping Central Hospital   (China)

^b Jilin Zhongke Bio engineering Co Ltd   (China)

^c Canton People's Provincial Hospital   (China)

Author keywords

amniotic stem cell transplantation; glycosylated haemoglobin (HbA1c); insulin; Type 1 diabetes mellitus

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL MARKER; CELL PROTEIN; CELL SURFACE MARKER; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DR ANTIGEN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PENICILLIN V; TRIACYLGLYCEROL;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; AMNION; AMNION CELL; AMNIOTIC STEM CELL TRANSPLANTATION; ANTIBIOTIC THERAPY; ARTICLE; BLOOD GLUCOSE MONITORING; CASE REPORT; CELL ADHESION; CELL CULTURE; CELL EXPANSION; CELL ISOLATION; CELL STRUCTURE; CHILDBIRTH; CHINA; CHOLESTEROL BLOOD LEVEL; COLONY FORMATION; CULTURE MEDIUM; CULTURE TECHNIQUE; DRUG DOSE REDUCTION; ENDOTHELIAL PROGENITOR CELL; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HLA SYSTEM; HOSPITAL ADMISSION; HUMAN; IMMUNOCYTOCHEMISTRY; INCUBATION TEMPERATURE; INCUBATION TIME; INFECTION; INFECTION PREVENTION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATIENT MONITORING; PHENOTYPE; POSTPRANDIAL STATE; PROTEIN LOCALIZATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84887341864     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513487640     Document Type: Article

References (24)

1. Badran M,Laher I.Type II diabetes mellitus in Arabic-speaking countries.Int J Endocrinol. 2012;2012:902873-902873.
2. Zelezniak A,Pers TH,Soares S,et al.Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes.PLoS Comput Biol. 2010;6:e1000729-e1000729.
3. Baruah MP,Kalra S,Unnikrishnan AG,et al.Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines.Indian J Endocrinol Metab. 2011;15:75-90.
4. Smith-Spangler CM,Bhattacharya J,Goldhaber-Fiebert JD.Diabetes, its treatment, and catastrophic medical spending in 35 developing countries.Diabetes Care. 2012;35:319-326.
5. Hu FB.Globalization of diabetes: the role of diet, lifestyle, and genes.Diabetes Care. 2011;34:1249-1257.
6. Qiao H,Zhao T,Wang Y,et al.Isolation, purification and identification of epithelial cells derived from fetal islet-like cell clusters.Sheng Wu Gong Cheng Xue Bao. 2007;23:246-251.
7. Truong W, Lakey JR, Ryan EA,et al.Clinical islet transplantation at the University of Alberta - the Edmonton experience. Clin Transpl 2005; 153-172. http://www.ncbi.nlm.nih.gov/pubmed/17424733.
8. Chhabra P,Brayman KL.Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.J Transplant. 2011;2011:637692-637692.
9. Kadam S,Muthyala S,Nair P,et al.Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as novel source for stem cell therapy in diabetes.Rev Diabet Stud. 2010;7:168-182.
10. Evangelista M,Soncini M,Parolini O.Placenta-derived stem cells: new hope for cell therapy?.Cytotechnology. 2008;58:33-42.
11. Kang JW,Koo HC,Hwang Y,et al.Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells.J Vet Sci. 2012;13:23-31.
12. Castrechini NM,Murthi P,Gude NM,et al.Mesenchymal stem cells in human placental chorionic villi reside in a vascular Niche.Placenta. 2010;31:203-212.
13. Liu YH,Vaghjiani V,Tee JY,et al.Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.PLoS One. 2012;7:e35758-e35758.
14. Chen PM,Yen ML,Liu KJ,et al.Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells.J Biomed Sci. 2011;18:49-49.
15. Koo BK,Park IY,Kim J,et al.Isolation and characterization of chorionic mesenchymal stromal cells from human full term placenta.J Korean Med Sci. 2012;27:857-863.
16. Rossi D,Pianta S,Magatti M,et al.Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity.PLoS One. 2012;7:e46956-e46956.
17. Pratama G,Vaghjiani V,Tee JY,et al.Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications.PLoS One. 2011;6:e26136-e26136.
18. Broughton BS,Lim R,Arumugam TV,et al.Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion epithelial cells.Front Cell Neurosci. 2012;6:66-66.
19. Lisi A,Briganti E,Ledda M,et al.A combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells.PLoS One. 2012;7:e34284-e34284.
20. Reyes M,Dudek A,Jahagirdar B,et al.Origin of endothelial progenitors in human postnatal bone marrow.J Clin Invest. 2002;109:337-346.
21. Couri CE,Oliveira MC,Stracieri AB,et al.C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.JAMA. 2009;301:1573-1579.
22. Zhang X,Ye L,Hu J,et al.Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient.PLoS One. 2012;7:e31887-e31887.
23. Polgreen LE,Thomas W,MacMillan ML,et al.First phase insulin release and glucose tolerance in children with Fanconi anemia after hematopoietic cell transplantation.Pediatr Blood Cancer. 2009;53:191-196.
24. Trivedi HL,Vanikar AV,Thakker U,et al.Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin.Transplant Proc. 2008;40:1135-1139.